KRAS and BRAF mutated CRCs are associated with distinct clinicopathological features according to a large cohort of CRC in Western entity, where RAS mutation is associated with male gender and classical adenocarcinoma subtype (39). The gene discussed is BRAF; the disease is colorectal carcinoma.